Author

Arturo Borzutzky

0 works0 citationsORCID

Recent research

Health & Medicine
PROTEGO Study Protocol: A Cluster Randomised Crossover Trial of Vernix Caseosa Retention for Primary Prevention of Atopic Dermatitis
Summary PROTEGO is a Chilean cluster‐randomised crossover trial of vernix caseosa retention to prevent atopic dermatitis. 1383 mother‐infant dyads will be enrolled and followed for atopic dermatitis until 12 months.
Clinical & Experimental Allergy2026-10-110 citationsDOI